REGENXBIO, Inc. (RGNX)
11.16
-0.44
(-3.79%)
USD |
NASDAQ |
Jan 30, 16:00
11.10
-0.06
(-0.54%)
After-Hours: 20:00
REGENXBIO Total Assets (Quarterly) : 525.20M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Omeros Corp. | 185.71M |
| Sarepta Therapeutics, Inc. | 3.493B |
| AbbVie, Inc. | 133.90B |
| CytomX Therapeutics, Inc. | 158.25M |
| Krystal Biotech, Inc. | 1.240B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 363.75M |
| Shareholders Equity (Quarterly) | 161.45M |
| Debt to Equity Ratio | 1.661 |
| Current Ratio | 2.665 |
| Net Debt Paydown Yield | -4.48% |